Loading...

Qiagen N.V.

QIA.DEXETRA
Healthcare
Medical - Diagnostics & Research
34.23
-0.72(-2.06%)
German Market is Open • 13:02

Qiagen N.V. Fundamental Analysis

Qiagen N.V. (QIA.DE) shows moderate financial fundamentals with a PE ratio of 19.87, profit margin of 20.33%, and ROE of 11.85%. The company generates $2.1B in annual revenue with weak year-over-year growth of 0.66%.

Key Strengths

Operating Margin23.36%
Cash Position15.29%
Current Ratio3.90

Areas of Concern

PEG Ratio2.88
We analyze QIA.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 56.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
56.4/100

We analyze QIA.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

QIA.DE struggles to generate sufficient returns from assets.

ROA > 10%
6.75%

Valuation Score

Moderate

QIA.DE shows balanced valuation metrics.

PE < 25
19.87
PEG Ratio < 2
2.88

Growth Score

Weak

QIA.DE faces weak or negative growth trends.

Revenue Growth > 5%
0.66%
EPS Growth > 10%
-74.68%

Financial Health Score

Excellent

QIA.DE maintains a strong and stable balance sheet.

Debt/Equity < 1
0.44
Current Ratio > 1
3.90

Profitability Score

Moderate

QIA.DE maintains healthy but balanced margins.

ROE > 15%
11.85%
Net Margin ≥ 15%
20.33%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is QIA.DE Expensive or Cheap?

P/E Ratio

QIA.DE trades at 19.87 times earnings. This indicates a fair valuation.

19.87

PEG Ratio

When adjusting for growth, QIA.DE's PEG of 2.88 indicates potential overvaluation.

2.88

Price to Book

The market values Qiagen N.V. at 2.23 times its book value. This may indicate undervaluation.

2.23

EV/EBITDA

Enterprise value stands at 10.54 times EBITDA. This signals the market has high growth expectations.

10.54

How Well Does QIA.DE Make Money?

Net Profit Margin

For every $100 in sales, Qiagen N.V. keeps $20.33 as profit after all expenses.

20.33%

Operating Margin

Core operations generate 23.36 in profit for every $100 in revenue, before interest and taxes.

23.36%

ROE

Management delivers $11.85 in profit for every $100 of shareholder equity.

11.85%

ROA

Qiagen N.V. generates $6.75 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.75%

Following the Money - Real Cash Generation

Operating Cash Flow

Qiagen N.V. generates strong operating cash flow of $649.02M, reflecting robust business health.

$649.02M

Free Cash Flow

Qiagen N.V. generates strong free cash flow of $448.60M, providing ample flexibility for dividends, buybacks, or growth.

$448.60M

FCF Per Share

Each share generates $2.18 in free cash annually.

$2.18

FCF Yield

QIA.DE converts 5.41% of its market value into free cash.

5.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

19.87

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.88

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.007

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.90

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.12

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How QIA.DE Stacks Against Its Sector Peers

MetricQIA.DE ValueSector AveragePerformance
P/E Ratio19.8729.17 Better (Cheaper)
ROE11.85%701.00% Weak
Net Margin20.33%-43676.00% (disorted) Strong
Debt/Equity0.440.34 Weak (High Leverage)
Current Ratio3.904.45 Strong Liquidity
ROA6.75%-18965.00% (disorted) Weak

QIA.DE outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Qiagen N.V.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

31.72%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

304.94%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

106.91%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ